Exploring MDE. To explore a different substance…

Names:
MDE · EVE · MDEA · N-Ethyl-MDA · N-Ethyl-3,4-methylenedioxyamphetamine · 3,4-Methylenedioxy-N-ethylamphetamine
IUPAC names:
1-(2H-1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine
1-(1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine
ID: 106 · Formula: C12H17NO2 · Molecular weight: 207.269
InChI: InChI=1S/C12H17NO2/c1-3-13-9(2)6-10-4-5-11-12(7-10)15-8-14-11/h4-5,7,9,13H,3,6,8H2,1-2H3

Benzenhõfer, U; Passie, T. Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. Addiction, 1 Aug 2010, 105 (8), 1355–1361. 794 kB. http://dx.doi.org/10.1111/j.1360-0443.2010.02948.x

Freudenmann, RW; Spitzer, M. Neuropsychopharmacology and toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). CNS Drug Rev., 1 Jun 2004, 10 (2), 89–216. 187 kB. http://dx.doi.org/10.1111/j.1527-3458.2004.tb00007.x

Dal Cason, TA. An evaluation of the potential for clandestine manufacture of 3,4-methylenedioxyamphetamine (MDA) analogs and homologs. J. Forensic Sci., 1 May 1990, 35 (3), 675–697. 2.2 MB. http://dx.doi.org/10.1520/JFS12874J

Braun, U; Shulgin, AT; Braun, G. Prüfung auf zentrale Aktivität und Analgesia von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylendioxyphenylisopropylamin. Arzneim. Forsch., 1 Jan 1980, 30 (5), 825–830. 1.5 MB.

Gouzoulis-Mayfrank, E; Hermle, L. Are the “entactogens” a distinct psychoactive substance class? In Heffter Review; Nichols, DE, Ed., Heffter Research Institute, Santa Fe, NM, 1998; Vol. 1, pp 46–51. 44 kB.

Gouzoulis-Mayfrank, E. Differential actions of an entactogen compared to a stimulant and a hallucinogen in healthy humans. In Heffter Review; Nichols, DE, Ed., Heffter Research Institute, Santa Fe, NM, 2001; Vol. 2, pp 64–72. 261 kB.

Noggle, FT; DeRuiter, J; Coker, ST; Clark, CR. Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine. J. Assoc. Off. Anal. Chem., 1987, 70 (6), 981–986. 1.8 MB.

Krawczeniuk, AS. Identification of phenethylamines and methylenedioxyamphetamines using liquid chromatography atmospheric pressure electrospray ionization mass spectrometry. Microgram J., 1 Jan 2005, 3 (1–2), 78–100. 979 kB.

Maurer, HH; Kraemer, T; Springer, D; Staack, RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophenone types. A synopsis. Ther. Drug Monit., 1 Apr 2004, 26 (2), 127–131. 121 kB.

Al-Hossaini, AM. GC-MS and GC-IRD studies on ethoxyphenethylamines related to MDEA, MDMMA and MBDB. Ph. D. Thesis, Auburn University, Auburn, AL, USA, 18 Dec 2009. 1.2 MB.

Shulgin, AT. Making MDA, MDEA, MDMA. Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 15 Mar 2001.

Thigpen, AL; Awad, T; DeRuiter, J; Clark, CR. GC-MS studies on the regioisomeric methoxy-methyl-phenethylamines related to MDEA, MDMMA, and MBDB. J. Chromatogr. Sci., 1 Nov 2008, 46 (10), 900–206. 448 kB. http://dx.doi.org/10.1093/chromsci/46.10.900

Thigpen, AL; DeRuiter, J; Clark, CR. GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB. J. Chromatogr. Sci., 1 May 2007, 45 (5), 229–235. 332 kB. http://dx.doi.org/10.1093/chromsci/45.5.229

Braun, U; Shulgin, AT; Braun, G. Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine). J. Pharm. Sci., 1 Jan 1980, 69 (2), 192–195. 513 kB. http://dx.doi.org/10.1002/jps.2600690220

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Nieddu, M; Burrai, L; Pirisi, MA; Carta, A; Briguglio, I; Dessi, G; Boatto, G. Validated liquid chromatography-mass spectrometry method for the quantitation of N-substituted derivatives of 3,4-methylenedioxyamphetamine in rat urine. Forensic Toxicol., 1 Jul 2013, 31 (2), 204–211. 527 kB. http://dx.doi.org/10.1007/s11419-013-0178-5

Trachsel, D. Fluorine in psychedelic phenethylamines. Drug Test. Analysis, 1 Jul 2012, 4 (7-8), 577-590. 1.0 MB. http://dx.doi.org/10.1002/dta.413

Hermle, L; Fünfgeld, M; Oepen, G; Botsch, H; Borchardt, D; Gouzoulis, E; Fehrenbach, RA; Spitzer, M. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research. Biol. Psychiat., 1 Dec 1992, 32 (11), 976–991. 1.6 MB. http://dx.doi.org/10.1016/0006-3223(92)90059-9

Stone, DM; Johnson, M; Hanson, GR; Gibb, JW. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol., 10 Feb 1987, 134 (2), 245–248. 316 kB. http://dx.doi.org/10.1016/0014-2999(87)90173-7

Nash, JF; Nichols, DE. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Eur. J. Pharmacol., 1 Jan 1991, 200 (1), 53–58. 714 kB. http://dx.doi.org/10.1016/0014-2999(91)90664-C

Świst, M; Wilamowski, J; Zuba, D; Kochana, J; Parczewski, A. Determination of synthesis route of 1-(3,4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA. Forensic Sci. Int., 10 May 2005, 149 (2–3), 181–192. 594 kB. http://dx.doi.org/10.1016/j.forsciint.2004.06.016

McKenna, DJ; Guan, AM; Shulgin, AT. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav., 1 Jan 1991, 38 (3), 505–12. 783 kB. http://dx.doi.org/10.1016/0091-3057(91)90005-M

Schmidt, WJ; Mayerhofer, A; Meyer, A; Kovar, K. Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? Neurosci. Lett., 27 Sep 2002, 330 (3), 251–254. 280 kB. http://dx.doi.org/10.1016/S0304-3940(02)00823-6

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. http://dx.doi.org/10.1016/j.forsciint.2011.11.003

Glennon, RA; Yousif, M; Patrick, G. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol. Biochem. Behav., 1 Mar 1988, 29 (3), 443–449. 551 kB. http://dx.doi.org/10.1016/0091-3057(88)90001-9

FLEA
MDA
MDAL
MDBU
MDBZ
MDCPM
MDDM
MDHOET
MDIP
MDMA
MDMEO
MDMEOET
MDOH
MDPL
MDPR
MDIB
MDTB
MDAM
MDHE
MDOC
MDDEA · MDDE
MDCM
MDBA
MDTFEA
MDMEA
MDMPA
MDMIPA
MDSB
N-Formyl-MDMA
EBDB · ETHYL-J
ETHYL-K
ETHYL-L
N-Et-MDPEA
F2-MDE
DHEA
6622
EDEA
6-EAPB
5-EAPB
6-EAPDB
5-EAPDB
homo-MDPEA · GAMMA
Safrole
α-Isosafrole
β-Isosafrole
ONE · MDC
MDPPP
5,6-MDAI
EtONE · Ethylone
6,7-MDAT
α-Me-N-Et-MDBA
α-MMDBA
MDBZP · Methylenedioxybenzylpiperazine
homo-MDA
homo-MDE
MDCPA
499
MDAR
2563
2566
MDEAR
DMCPA
MADAM-6
MDDM
MDMC
MDMP
METHYL-J
F
IDA
K
2C-G-2
MADAM-2
2C-VI
DOMAI · DOM-AI
4-MeO-3-Me-MCAT
5,8-ADT
MeO-B · 4-Methoxybuphedrone
DMA-2-hemiFLY
4-Propoxycathinone
α-Me-N-Pr-MDBA
α,α,N,N-TMMDBA
homo-MDMA
α-Me-N-iPr-MDBA
BO3A
Hordenine acetate
2,3-MDDMA
2,3-MDE
2,3-MBDB
MAPEA
N-Me-N-Et-MDPEA
N-Pr-MDPEA
N-iPr-MDPEA
α-Et-MDA
α-iPr-MDPEA
ED-N-DMPEA
2,5-DMA-hemiFly-5 · SF
G-1
M-7
N-Et-ADTN
1095
1084
1006
FLEA
MDA
MDAL
MDBU
MDBZ
MDCPM
MDDM
MDHOET
MDIP
MDMA
MDMEO
MDMEOET
MDOH
MDPL
MDPR
MDIB
MDTB
MDAM
MDHE
MDOC
MDDEA · MDDE
MDCM
MDBA
MDTFEA
MDMEA
MDMPA
MDMIPA
MDSB
N-Formyl-MDMA
EBDB · ETHYL-J
ETHYL-K
ETHYL-L
N-Et-MDPEA
F2-MDE
DHEA
6622
EDEA
6-EAPB
5-EAPB
6-EAPDB
5-EAPDB
homo-MDPEA · GAMMA
Safrole
α-Isosafrole
β-Isosafrole
ONE · MDC
MDPPP
5,6-MDAI
EtONE · Ethylone
6,7-MDAT
α-Me-N-Et-MDBA
α-MMDBA
MDBZP · Methylenedioxybenzylpiperazine
homo-MDA
homo-MDE
MDCPA
499
MDAR
2563
2566
MDEAR
DMCPA
MADAM-6
MDDM
MDMC
MDMP
METHYL-J
F
IDA
K
2C-G-2
MADAM-2
2C-VI
DOMAI · DOM-AI
4-MeO-3-Me-MCAT
5,8-ADT
MeO-B · 4-Methoxybuphedrone
DMA-2-hemiFLY
4-Propoxycathinone
α-Me-N-Pr-MDBA
α,α,N,N-TMMDBA
homo-MDMA
α-Me-N-iPr-MDBA
BO3A
Hordenine acetate
2,3-MDDMA
2,3-MDE
2,3-MBDB
MAPEA
N-Me-N-Et-MDPEA
N-Pr-MDPEA
N-iPr-MDPEA
α-Et-MDA
α-iPr-MDPEA
ED-N-DMPEA
2,5-DMA-hemiFly-5 · SF
G-1
M-7
N-Et-ADTN
1095
1084
1006
24 July 2017 · Creative Commons BY-NC-SA ·